Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.
2.

Conization using the Shimodaira-Taniguchi procedure for adenocarcinoma in situ of the uterine cervix.

Hiramatsu K, Ueda Y, Yoshino K, Fujita M, Morii E, Enomoto T, Kimura T.

Eur J Obstet Gynecol Reprod Biol. 2013 Jun;168(2):218-21. doi: 10.1016/j.ejogrb.2013.01.011. Epub 2013 Feb 8.

PMID:
23395556
3.
4.

Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.

McHale MT, Le TD, Burger RA, Gu M, Rutgers JL, Monk BJ.

Obstet Gynecol. 2001 Nov;98(5 Pt 1):726-31.

PMID:
11704160
5.

Conservative management of adenocarcinoma in situ of the cervix.

Shin CH, Schorge JO, Lee KR, Sheets EE.

Gynecol Oncol. 2000 Oct;79(1):6-10.

PMID:
11006022
6.

Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.

Taylor JS, Panico V, Caputo T, Gerber D, Gupta D, Pirog E, Holcomb K.

Eur J Gynaecol Oncol. 2014;35(6):641-5.

PMID:
25556268
7.

The safety of conization in the management of adenocarcinoma in situ of the uterine cervix.

Kim ML, Hahn HS, Lim KT, Lee KH, Kim HS, Hong SR, Kim TJ.

J Gynecol Oncol. 2011 Mar 31;22(1):25-31. doi: 10.3802/jgo.2011.22.1.25.

8.

Conservative treatment of stage IA1 adenocarcinoma of the uterine cervix with a long-term follow-up.

Yahata T, Nishino K, Kashima K, Sekine M, Fujita K, Sasagawa M, Honma S, Kodama S, Tanaka K.

Int J Gynecol Cancer. 2010 Aug;20(6):1063-6. doi: 10.1111/IGC.0b013e3181e768b6.

PMID:
20683418
9.

Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.

Bull-Phelps SL, Garner EI, Walsh CS, Gehrig PA, Miller DS, Schorge JO.

Gynecol Oncol. 2007 Nov;107(2):316-9. Epub 2007 Aug 8.

PMID:
17689593
10.

Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.

Costa S, Negri G, Sideri M, Santini D, Martinelli G, Venturoli S, Pelusi C, Syrjanen S, Syrjanen K, Pelusi G.

Gynecol Oncol. 2007 Jul;106(1):170-6. Epub 2007 May 4.

PMID:
17481701
11.

Further study of the management of cervical adenocarcinoma in situ.

Kennedy AW, Biscotti CV.

Gynecol Oncol. 2002 Sep;86(3):361-4.

PMID:
12217762
12.

Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases.

Costa S, Venturoli S, Negri G, Sideri M, Preti M, Pesaresi M, Falasca A, Barbieri D, Zerbini M, Santini D, Sandri MT, Ghiringhello B, Caroppo Venturini N, Syrjänen S, Syrjänen K.

Gynecol Oncol. 2012 Mar;124(3):490-5. doi: 10.1016/j.ygyno.2011.11.039. Epub 2011 Dec 1.

PMID:
22188786
13.

Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.

Munro A, Codde J, Spilsbury K, Stewart CJ, Steel N, Leung Y, Tan J, Salfinger SG, Mohan GR, Semmens JB, Cohen PA.

Acta Obstet Gynecol Scand. 2017 Apr;96(4):432-437. doi: 10.1111/aogs.13110. Epub 2017 Mar 6.

PMID:
28181670
14.

Cervical adenocarcinoma in situ: the predictive value of conization margin status.

Young JL, Jazaeri AA, Lachance JA, Stoler MH, Irvin WP, Rice LW, Andersen WA, Modesitt SC.

Am J Obstet Gynecol. 2007 Aug;197(2):195.e1-7; discussion 195.e7-8.

PMID:
17689647
15.

Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.

Im DD, Duska LR, Rosenshein NB.

Gynecol Oncol. 1995 Nov;59(2):179-82. Review.

PMID:
7590468
16.

Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.

Ostör AG, Duncan A, Quinn M, Rome R.

Gynecol Oncol. 2000 Nov;79(2):207-10.

PMID:
11063645
17.

Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.

Poynor EA, Barakat RR, Hoskins WJ.

Gynecol Oncol. 1995 May;57(2):158-64. Review.

PMID:
7729727
18.

Margin status and excision of cervical intraepithelial neoplasia: a review.

Jakus S, Edmonds P, Dunton C, King SA.

Obstet Gynecol Surv. 2000 Aug;55(8):520-7. Review.

PMID:
10945195
19.

Predictors and clinical significance of the positive cone margin in cervical intraepithelial neoplasia III patients.

Sun XG, Ma SQ, Zhang JX, Wu M.

Chin Med J (Engl). 2009 Feb 20;122(4):367-72.

PMID:
19302737
20.

The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma.

Lee SW, Kim YM, Son WS, You HJ, Kim DY, Kim JH, Kim YT, Nam JH.

Acta Obstet Gynecol Scand. 2009;88(2):209-15. doi: 10.1080/00016340802596009.

PMID:
19093236

Supplemental Content

Support Center